Navigation Links
Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidanc
Date:5/1/2013

r>without the effect of changes in foreign exchange rates.  These results convert our local foreign currency operating results to
the US Dollar at constant exchange rates of 0.833 Euro to 1.00 US Dollar and 110 Yen to 1.00 US Dollar.  They also exclude
the results of our foreign currency hedging program described in Note 7 to our consolidated financial statements in our Form
10-K.Three Months Ended3/30/20133/31/2012Non-GAAP revenuesGAAP revenue$249,942$186,670Foreign currency effects(13,250)(14,614)Non-GAAP revenue - constant currency$236,692$172,056Non-GAAP net incomeNon-GAAP net income, adjusted for restructuring and transformation costs$25,064$20,650Foreign currency effects(7,105)(6,401)Income tax associated with foreign currency effects1,5321,586Non-GAAP net income - constant currency$19,491$15,835Non-GAAP net income per common share assuming dilutionNon-GAAP net income per common share assuming dilution, adjusted for
restructuring and transformation costs$0.48$0.40Foreign currency effects after tax per common share assuming dilution$

(0.11)$

(0.09)Non-GAAP net income per common share assuming dilution - constant
currency$0.37$0.31 

 Reconciliation of Non-GAAP Measures for FY13 and FY12Year Ended3/30/20133/31/2012Non-GAAP gross profitGAAP gross profit$428,131$369,240Whole blood acquisition cost of good sold adjustment15,715—Whole blood Y connector inventory reserves7,046—Restructuring and transformation costs(428)1,510Non-GAAP gross profit$450,464$370,750Non-GAAP R&DGAAP R&D$48,641$36,801Restructuring and transformation costs(8,345)(2,864)Non-GAAP R&D$40,296$33,937Non-GAAP S,G&AGAAP S,G&A$318,806$245,261Restructuring and transformation costs(41,780)(14,947)Non-GAAP S,G&A$277,026$230,314Non-GAAP operating expensesGAAP operating expenses$371,694$280,482Restructuring and transformation costs(50,125)(17,811)Contingent consideration income—1,580Non-GAAP operatin
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Haemonetics Sets Date for Investor/Analyst Meeting
2. Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
3. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
4. Haemonetics Completes Acquisition of Palls Transfusion Medicine Business
5. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
6. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
7. CVS Caremark Reports Strong First Quarter Results
8. Questcor Reports First Quarter Financial Results
9. Cynosure Reports First-Quarter 2013 Financial Results
10. Luminex Corporation Reports First Quarter 2013 Results
11. HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)...  Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ... subsidiary, Dougherty,s Holdings, has acquired Springtown Drug (" ... Springtown, Texas , just north of ... pharmacy has provided retail prescriptions, healthcare products and gifts ... . The Springtown ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015 The ... reversed statewide since Pennsylvania State ... life-saving drug kits, naloxone. Heroin and opioid ... Pennsylvania , killing more individuals than ... approximately 2,400 Pennsylvanians died from a drug overdose. ...
(Date:8/31/2015)... , Aug. 31, 2015 Regen BioPharma, ... development of a novel means of delivering its ... RGBP-248, to liver tumors utilizing a clinically approved ... overcomes previous hurdles with gene silencing therapeutics in ... delivered throughout the whole body.  By utilizing a ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... June 9 Halozyme Therapeutics,Inc. (Nasdaq: ... products targeting the extracellular matrix, today,announced new ... mellitus program at,the American Diabetes Association,s 68th ... company,s proprietary recombinant human,hyaluronidase enzyme (rHuPH20) with ...
... Pivotal Study Highlighted at Recent Arizona Alzheimer,s ... Consortium Annual Conference in Phoenix -, PHOENIX and ... Health Research Institute today announced that they are,actively enrolling patients ... treatment of Alzheimer,s disease. The study will,evaluate the safety and ...
Cached Medicine Technology:Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3
(Date:9/1/2015)... ... ... The premier online medical education company for Podiatrists and ... podiatric, surgical and wound care conferences . The Residency Education Summits standardize and ... podium and across the table during hands-on surgical and advanced wound care workshops. ...
(Date:8/31/2015)... ... ... The PT Outcomes Registry is an organized system for collecting data to evaluate ... being developed by the American Physical Therapy Association (APTA). , Al Amato, PT, MBA, ... FOTO Outcomes measures as one of the primary global outcomes measures to be used ...
(Date:8/31/2015)... ... August 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics ... of Power and Influence by Modern Luxury’s The Atlantan Magazine. , This ... well as Kathy King. Her idea and vision to bring to Atlanta a ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... Diabetes Institute (WDI) at Western University of Health Sciences to learn more about ... of Periodontology, School of Dental Sciences and Institute of Cellular Medicine at Newcastle ...
(Date:8/31/2015)... Los Angeles, CA (PRWEB) , ... August 31, 2015 , ... ... August 16 by CDA Press, the expert guest author addressed the topic of treating ... The author explained that, while steroids were shown to slightly improve physical function in ...
Breaking Medicine News(10 mins):Health News:PRESENT e-Learning Systems Announces their 2016 Podiatry and Wound Care Medical Education Conference Schedule 2Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2
... have found that high doses of the common painkiller like ... a heart attack if taken in high doses for a ... that there was no danger for occasional users, and its ... who depend on it to lead normal lives. They claimed ...
... today dismissed the medical negligence claim to the tune ... //who had alleged that his wife died because of ... Consumer Disputes Redressal Commission Bench comprising Justice M B ... in its judgment, absolved five Kolkata-based doctors - Sukumar ...
... According to a study by Premera Blue Cross, it ... $1 billion to cover shortfalls incurred by hospitals and ... ,Gubby Barlow, chief executive officer of Mountlake ... cost-shifting. Others call it a hidden tax’. Thus it ...
... children get 'spellbound' in local contests every year with 275 ... it// to the finals of the prestigious Scripps National Spelling ... ,With the bee's soaring popularity, the championship round will ... first time as 139 boys and 136 girls, making up ...
... hospitals in Delhi were once again buzzing with activity ... , who called off their nearly three-week-long anti-quota strike ... services were showing signs of normalcy with patients thronging ... Sciences, Safdarjung, Maulana Azad Medical College, Ram Manohar Lohia ...
... introduction of a UN AIDS report, UN officials were prompted ... in Myanmar and Vietnam // , which is inadequate prevention ... was originally a HIV/AIDS haven, has shown remarkable decline in ... measures to combat AIDS go slack, there is a risk ...
Cached Medicine News:Health News:High Doses Of Common Pain killers Can Double The Chances Of Heart attack 2Health News:Indian Americans Compete for the Prestigious Spelling Bee Contest 2